Cooley S - Search Results

1

Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.

Warlick ED, Tomblyn M, Cao Q, Defor T, Blazar BR, Macmillan M, Verneris M, Wagner J, Dusenbery K, Aurora M, Bachanova V, Brunstein C, Burns L, Cooley S, Kaufman D, Majhail NS, McClune B, McGlave P, Miller J, Oran B, Slungaard A, Vercellotti G, Weisdorf DJ. Warlick ED, et al. Among authors: cooley s. Biol Blood Marrow Transplant. 2011 Jul;17(7):1025-32. doi: 10.1016/j.bbmt.2010.10.030. Epub 2010 Nov 1. Biol Blood Marrow Transplant. 2011. PMID: 21047561 Free PMC article. Clinical Trial.

2

KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.

Cooley S, McCullar V, Wangen R, Bergemann TL, Spellman S, Weisdorf DJ, Miller JS. Cooley S, et al. Blood. 2005 Dec 15;106(13):4370-6. doi: 10.1182/blood-2005-04-1644. Epub 2005 Aug 30. Blood. 2005. PMID: 16131567 Free PMC article.

3

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

Miller JS, Cooley S, Parham P, Farag SS, Verneris MR, McQueen KL, Guethlein LA, Trachtenberg EA, Haagenson M, Horowitz MM, Klein JP, Weisdorf DJ. Miller JS, et al. Among authors: cooley s. Blood. 2007 Jun 1;109(11):5058-61. doi: 10.1182/blood-2007-01-065383. Epub 2007 Feb 22. Blood. 2007. PMID: 17317850 Free PMC article.

4

A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.

Cooley S, Xiao F, Pitt M, Gleason M, McCullar V, Bergemann TL, McQueen KL, Guethlein LA, Parham P, Miller JS. Cooley S, et al. Blood. 2007 Jul 15;110(2):578-86. doi: 10.1182/blood-2006-07-036228. Epub 2007 Mar 28. Blood. 2007. PMID: 17392508 Free PMC article.

5

Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.

Miller JS, Weisdorf DJ, Burns LJ, Slungaard A, Wagner JE, Verneris MR, Cooley S, Wangen R, Fautsch SK, Nicklow R, Defor T, Blazar BR. Miller JS, et al. Among authors: cooley s. Blood. 2007 Oct 1;110(7):2761-3. doi: 10.1182/blood-2007-05-090340. Epub 2007 Jun 19. Blood. 2007. PMID: 17579184 Free PMC article.

6

First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer.

Dudek AZ, Yunis C, Harrison LI, Kumar S, Hawkinson R, Cooley S, Vasilakos JP, Gorski KS, Miller JS. Dudek AZ, et al. Among authors: cooley s. Clin Cancer Res. 2007 Dec 1;13(23):7119-25. doi: 10.1158/1078-0432.CCR-07-1443. Clin Cancer Res. 2007. PMID: 18056192 Clinical Trial.

7

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Cooley S, Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le CT, Marsh SG, Guethlein LA, Parham P, Miller JS, Weisdorf DJ. Cooley S, et al. Blood. 2009 Jan 15;113(3):726-32. doi: 10.1182/blood-2008-07-171926. Epub 2008 Oct 22. Blood. 2009. PMID: 18945962 Free PMC article.

8

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

Brunstein CG, Wagner JE, Weisdorf DJ, Cooley S, Noreen H, Barker JN, DeFor T, Verneris MR, Blazar BR, Miller JS. Brunstein CG, et al. Among authors: cooley s. Blood. 2009 May 28;113(22):5628-34. doi: 10.1182/blood-2008-12-197467. Epub 2009 Mar 27. Blood. 2009. PMID: 19329778 Free PMC article.

9

"Self"-reflection by KIR.

Cooley S, Miller JS. Cooley S, et al. Blood. 2009 Jul 2;114(1):2-3. doi: 10.1182/blood-2009-04-214312. Blood. 2009. PMID: 19574478 Free article.

10

Cellular adoptive immunotherapy after autologous and allogeneic hematopoietic stem cell transplantation.

Porter DL, Hexner EO, Cooley S, Miller JS. Porter DL, et al. Among authors: cooley s. Cancer Treat Res. 2009;144:497-537. doi: 10.1007/978-0-387-78580-6_20. Cancer Treat Res. 2009. PMID: 19779876 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters